Urologix Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	2009 - 2005
Period Ending	Mar '26 Mar 3, 2026	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010	2009 - 2005
Market Capitalization	0	4	4	15	14	16	Upgrade
Market Cap Growth	-98.94%	4.29%	-77.19%	11.19%	-10.86%	-13.42%	Upgrade
Enterprise Value	-	8	-2	14	10	10	Upgrade
Last Close Price	0.00	0.17	0.17	0.77	0.95	1.07	Upgrade
PS Ratio	0.00	0.26	0.21	0.91	1.10	1.05	Upgrade
PB Ratio	0.00	-0.52	8.37	24.60	2.86	1.89	Upgrade
P/TBV Ratio	-	-	-	-	2.92	1.92	Upgrade
EV/Sales Ratio	-	0.58	-	0.80	0.80	0.66	Upgrade
Debt / Equity Ratio	-0.66	-0.76	12.70	-	-	-	Upgrade
Net Debt / Equity Ratio	-0.60	-0.66	7.25	-3.03	-0.63	-0.69	Upgrade
Net Debt / EBITDA Ratio	-12.98	-1.36	-0.85	0.60	1.00	3.90	Upgrade
Net Debt / FCF Ratio	-17.60	-2.95	-1.49	2.47	1.16	4.27	Upgrade
Asset Turnover	1.67	1.54	1.31	1.75	1.48	1.32	Upgrade
Inventory Turnover	4.81	5.47	5.39	6.72	4.59	4.52	Upgrade
Quick Ratio	0.31	0.52	1.68	0.55	2.52	3.55	Upgrade
Current Ratio	0.56	0.86	2.32	0.79	3.30	4.37	Upgrade
Return on Equity (ROE)	-	-	-820.65%	-171.60%	-57.20%	-23.93%	Upgrade
Return on Assets (ROA)	-7.62%	-27.30%	-21.11%	-24.87%	-26.69%	-12.63%	Upgrade
Return on Invested Capital (ROIC)	-	-721.71%	-113.15%	-1510.94%	-168.94%	-83.64%	Upgrade
Return on Capital Employed (ROCE)	79.00%	-288.90%	-43.00%	-71.80%	-72.40%	-27.50%	Upgrade
Earnings Yield	-219360.90%	-207.61%	-122.15%	-30.48%	-26.95%	-13.96%	Upgrade
FCF Yield	-12922.93%	-42.62%	-58.00%	-5.00%	-19.07%	-8.60%	Upgrade
Buyback Yield / Dilution	-2.26%	-2.49%	-40.45%	-1.27%	-0.33%	-0.27%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.